Skip to content

STUDY OF EVALUATION OF PERIOPERATIVE ISCHEMIA (POISE)

STUDY OF EVALUATION OF PERIOPERATIVE ISCHEMIA (POISE)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-009-04
Enrollment
17
Registered
2004-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Metoprolol Type of group
Metoprolol will be administered in patients with moderate to high risk who go to non-cardiac surgery. Group name:placebo Type of group
Metoprolol placebo will be administered in patients with moderate to high risk who go to non-cardiac surgery.

Sponsors

POPULATION HEALTH RESEARCH INSTITUTE DE LA UNIVERSIDAD MC MASTER DE CANADA,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. They are> 45 years old 2. They have an expectation of postoperative stay> at 24 hours for surgical reasons 3. Meet any of the following 6 criteria: A. history of coronary artery disease B. Vascular artery disease C. History of Stroke D. Hospitalization by ICC within 3 years prior to randomization. E. Patients going to vascular surgery

Exclusion criteria

Exclusion criteria: 1. Contraindication for metoprolol 2. There is a clinical need for beta-blocker use preoperatively or during the first 30 days postoperatively 3. Previous adverse reaction to a beta blocker 4. Coronary revascularization surgery in the previous 5 years and no evidence of cardiac ischemia since surgery 5. Patients who undergo low-risk surgical procedures

Design outcomes

Primary

MeasureTime frame
Outcome name:The patients heart rate and systolic blood pressure. Measure:Impact of the perioperative administration of metoprolol on cardiovascular events in the first 30 days after surgery in patients with moderate and high risk of postoperative cardiac events. Timepoints:6 to 12 hours immediately after the postoperative period, first, second and thirtieth postoperative days

Secondary

MeasureTime frame
Outcome name:significant atrial fibrillation, rehospitalization due to cardiac causes, AML, cardiac arrest, cardiovascular death, and the need for revascularization procedures. Measure:Perioperative effect of metoprolol at risk in the first 30 days of significant atrial fibrillation, rehospitalization due to cardiac causes, AML, cardiac arrest, cardiovascular death, and the need for revascularization procedures. Timepoints:30 first days

Countries

Peru

Outcome results

None listed

Source: REPEC (via WHO ICTRP)